Department of System Chemotherapy and Molecular Sciences, Division of Bioinformatics and Chemical Genomics, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.
Nat Prod Rep. 2016 May 4;33(5):648-54. doi: 10.1039/c5np00120j.
Covering: 1993 to 2016The exploitation of small molecules from natural sources, such as microbial metabolites, has contributed to the discovery of not only new drugs but also new research tools for chemical biology. My research team has discovered several novel bioactive small molecules using in vivo cell-based phenotypic screening, and has investigated their modes of action using chemical genetics and chemical genomics. This highlight focuses on our recent discoveries and chemical genetics approaches for bioactive microbial metabolites that target cancer cells, the cancer microenvironment and cell membrane signalling. In addition, the development of two new platforms, 5-sulfonyl tetrazole-based and thiourea-modified amphiphilic lipid-based probe technologies, to identify the cellular targets of these molecules is also discussed.
1993 年至 2016 年
从天然来源(如微生物代谢产物)中提取的小分子不仅为新药的发现做出了贡献,也为化学生物学的研究工具提供了新的思路。本研究团队利用体内基于细胞表型的筛选方法发现了几种新型生物活性小分子,并通过化学遗传学和化学基因组学研究了它们的作用模式。本综述重点介绍了我们最近发现的针对癌细胞、肿瘤微环境和细胞膜信号的生物活性微生物代谢产物的化学遗传学方法,此外还讨论了两种新平台——基于 5-磺酰基四唑的和硫脲修饰的两亲性脂基探针技术——用于鉴定这些分子的细胞靶标的发展。